Ophthalmologic Drug Guide

De (autor) , , ,
Notă GoodReads:
en Limba Engleză Carte Paperback – 03 Dec 2010

The updated second edition of this popular pocket guide includes newly available and FDA-approved drugs as well as guidance on using the growing number of drugs now prescribed for off-label purposes, such as anti-VEGF agents used in cancer treatments.

Citește tot Restrânge

Preț: 12660 lei

Preț vechi: 27521 lei

Puncte Express: 190

Preț estimativ în valută:
2535 2869$ 2163£

Carte tipărită la comandă

Livrare economică 22 aprilie-06 mai
Livrare express 23-30 martie pentru 24726 lei

Preluare comenzi: 021 569.72.76


ISBN-13: 9781441976208
ISBN-10: 1441976205
Pagini: 160
Ilustrații: 106 schwarz-weiße Tabellen
Dimensiuni: 127 x 203 x 13 mm
Greutate: 0.20 kg
Ediția: 2nd ed. 2011
Editura: Springer
Colecția Springer
Locul publicării: New York, NY, United States

Public țintă



Antibacterial Agents.- Antifungal Agents.- Antiviral Agents.- Antiparasitic Agents.- Antiglaucoma Agents.- Neuro-ophthalmology.- Retina.- Antiinflammatory Agents.- Mydriatics, Cycloplegics, and Reversal Agents.- Lubricants and Viscoelastics.- Miscellaneous (Appendices) Topical Antibacterial Spectrum.- Preparing Fortified Topical Antibiotics and Oral Acetazolamide Solution.- Antifungal Activity Spectrum.- Renal Dosing for Selected Drugs.- Glaucoma Medication Preservatives.- Product Index.- Subject Index.

Notă biografică

Douglas J. Rhee, MDAssistant ProfessorHarvard Medical SchoolAssociate Chief, Practice DevelopmentMassachusetts Eye & Ear InfirmaryBoston, Massachusetts USA Katheryn A. Colby, MD, PhDAssistant Professor Harvard Medical SchoolCornea ServiceMassachusetts Eye & Ear InfirmaryBoston, Massachusetts USA Christopher J. Rapuano, MDProfessorJefferson Medical CollegeDirector, Cornea ServiceWills Eye HospitalPhiladelphia, Pennsylvania USA Lucia Sobrin, MD, MPHAssistant ProfessorHarvard Medical SchoolMassachusetts Eye & Ear InfirmaryBoston, Massachusetts USA

Textul de pe ultima copertă

The updated edition of this popular pocket guide includes new drugs available and FDA-approved since publication of the first edition and also guidance on using the growing number of drugs now prescribed for off-label purposes, such as anti-VEGF agents, used in cancer treatments, which are also being used to stop cell growth in age-related macular degeneration. Drugs are grouped by presenting disease (e.g., glaucoma, retinal disease, cataracts), and readers may also access information via the Product Index or the Subject Index. The entire book is presented in a table format to facilitate quick look-up.


All-inclusive formulary for ocular prescription medications
Three ways to access drug information: by disease, by product name, and by topic
Presented in table format, to facilitate quick look-up New edition includes new agents in retinal disease and glaucoma